Silicon Laboratories Statistics
Share Statistics
Silicon Laboratories has 32.57M
shares outstanding. The number of shares has increased by 1.72%
in one year.
| Shares Outstanding | 32.57M |
| Shares Change (YoY) | 1.72% |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 1.81M, so 5.55% of the outstanding
shares have been sold short.
| Short Interest | 1.81M |
| Short % of Shares Out | 5.55% |
| Short % of Float | 9.68% |
| Short Ratio (days to cover) | 4.7 |
Valuation Ratios
The PE ratio is -21.53 and the forward
PE ratio is 49.56.
Silicon Laboratories's PEG ratio is
-0.05.
| PE Ratio | -21.53 |
| Forward PE | 49.56 |
| PS Ratio | 7.04 |
| Forward PS | 3.7 |
| PB Ratio | 3.81 |
| P/FCF Ratio | -160.32 |
| PEG Ratio | -0.05 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Silicon Laboratories.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.15,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.15 |
| Quick Ratio | 5.07 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.15 |
| Debt / FCF | -0.61 |
| Interest Coverage | -126.33 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $309,362.63 |
| Profits Per Employee | $-101,116.99 |
| Employee Count | 1,889 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.58 |
Taxes
| Income Tax | 36.2M |
| Effective Tax Rate | -23.38% |
Stock Price Statistics
The stock price has increased by 0.36% in the
last 52 weeks. The beta is 1.36, so Silicon Laboratories's
price volatility has been higher than the market average.
| Beta | 1.36 |
| 52-Week Price Change | 0.36% |
| 50-Day Moving Average | 110.78 |
| 200-Day Moving Average | 118.83 |
| Relative Strength Index (RSI) | 57.67 |
| Average Volume (20 Days) | 425,385 |
Income Statement
In the last 12 months, Silicon Laboratories had revenue of 584.39M
and earned -191.01M
in profits. Earnings per share was -5.93.
| Revenue | 584.39M |
| Gross Profit | 312.19M |
| Operating Income | -165.49M |
| Net Income | -191.01M |
| EBITDA | -104.92M |
| EBIT | -153.5M |
| Earnings Per Share (EPS) | -5.93 |
Full Income StatementBalance Sheet
The company has 281.61M in cash and 15.55M in
debt, giving a net cash position of 266.06M.
| Cash & Cash Equivalents | 281.61M |
| Total Debt | 15.55M |
| Net Cash | 266.06M |
| Retained Earnings | 1B |
| Total Assets | 1.23B |
| Working Capital | 498.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -13.91M
and capital expenditures -11.75M, giving a free cash flow of -25.66M.
| Operating Cash Flow | -13.91M |
| Capital Expenditures | -11.75M |
| Free Cash Flow | -25.66M |
| FCF Per Share | -0.8 |
Full Cash Flow StatementMargins
Gross margin is 53.42%, with operating and profit margins of -28.32% and -32.69%.
| Gross Margin | 53.42% |
| Operating Margin | -28.32% |
| Pretax Margin | -26.49% |
| Profit Margin | -32.69% |
| EBITDA Margin | -17.95% |
| EBIT Margin | -28.32% |
| FCF Margin | -4.39% |
